What's Happen Under the Calcification Process in Pseudoxanthoma Elasticum
NCT03070860 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2018-06-28
Summary
The investigators hypothesize is that in PXE patients, low grade chronic inflammation could preceed the molecular and the clinical calcification process.
Conditions
- Pseudoxanthoma Elasticum
Interventions
- RADIATION
-
PET scan 18-FDG and 18-NAF
Positron emission tomography (PET) is a medical imaging test performed in a nuclear medicine department. PET scan is performed by IV injection of a mildly radioactive tracer (NAF and FDG).
Sponsors & Collaborators
-
University Hospital, Angers
lead OTHER_GOV
Principal Investigators
-
Loukman OMARJEE, MD,MSc · University Hospital, Angers
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- France
Study Locations
More Related Trials
-
Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms
NCT03288597 ·Status: UNKNOWN
-
Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy
NCT04942275 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake
NCT00671242 ·Status: COMPLETED
-
PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents
NCT02325349 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
NCT04566185 ·Status: COMPLETED ·Phase: NA
-
Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer
NCT01336231 ·Status: TERMINATED
-
PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal Cancer
NCT04564482 ·Status: RECRUITING ·Phase: NA
-
Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma
NCT04561492 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
PET FDG Assessment of Change in Atherosclerotic Plaques After Chemotherapy
NCT00742352 ·Status: UNKNOWN
-
Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer
NCT02821936 ·Status: COMPLETED ·Phase: NA
-
RGD-PET-CT in Cancer Angiogenesis
NCT01492192 ·Status: TERMINATED ·Phase: PHASE2
-
Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer
NCT02507518 ·Status: UNKNOWN ·Phase: PHASE2
-
PET Imaging in Patients at Risk for Acute Lung Injury
NCT01486342 ·Status: COMPLETED
-
PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation
NCT02134639 ·Status: COMPLETED ·Phase: PHASE1
-
[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients
NCT05222269 ·Status: TERMINATED ·Phase: PHASE2
-
Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation
NCT03312712 ·Status: UNKNOWN
-
Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization
NCT02848638 ·Status: COMPLETED
-
Differentiation of Pseudoprogression and True Progression Through High Field Susceptibility Weighted Imaging and R2*
NCT02212964 ·Status: COMPLETED
-
Study of the Angiogenesis by PET/CT in Patients With Lymphoma
NCT02490891 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Impact of PET/CT on Radiation Treatment Planning in Relation to Changes in GTV in Stage 3 NSCLC
NCT01888692 ·Status: TERMINATED
-
Advanced Imaging for Pulmonary Fibrosis
NCT06532071 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
NCT02496013 ·Status: UNKNOWN ·Phase: PHASE1
-
18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the Pancreas
NCT01485679 ·Status: COMPLETED ·Phase: NA
-
Measuring Fatty Acid Oxidation in Cerebral Metastases Using [18F]FPIA
NCT04807582 ·Status: COMPLETED
-
Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI
NCT01525056 ·Status: COMPLETED ·Phase: PHASE2